miR-340 predicts glioblastoma survival and modulates key cancer hallmarks through down-regulation of NRAS

Glioblastoma is the most common primary brain tumor in adults; with a survival rate of 12 months from diagnosis. However, a small subgroup of patients, termed long-term survivors (LTS), has a survival rate longer then 12–14 months. There is thus increasing interest in the identification of molecular...

Descripción completa

Detalles Bibliográficos
Autores principales: Fiore, Danilo, Donnarumma, Elvira, Roscigno, Giuseppina, Iaboni, Margherita, Russo, Valentina, Affinito, Alessandra, Adamo, Assunta, De Martino, Fabio, Quintavalle, Cristina, Romano, Giulia, Greco, Adelaide, Soini, Ylermi, Brunetti, Arturo, Croce, Carlo M., Condorelli, Gerolama
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991399/
https://www.ncbi.nlm.nih.gov/pubmed/26799668
http://dx.doi.org/10.18632/oncotarget.6968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991399/
https://www.ncbi.nlm.nih.gov/pubmed/26799668
http://dx.doi.org/10.18632/oncotarget.6968

Ejemplares similares